Interposed Nucleus aDBS for Ataxia
NCT: NCT07325487 · RECRUITING
Brief Summary
This is a single-center, open-label study designed to evaluate the feasibility, safety, and preliminary efficacy of cerebellar adaptive deep brain stimulation (aDBS) in adults with spinocerebellar ataxia type 6 (SCA6). A total of 5 participants will be enrolled. Participants will undergo surgical implantation of deep brain stimulation (DBS) leads targeting the motor interposed nucleus of the cerebellum. The leads will be connected to one or two implantable pulse generators capable of delivering stimulation to deep brain structures and recording neural activity. Participants will complete up to 18 in-person study visits over a 24-month follow-up period. During these visits, neural signals will be recorded under varying behavioral tasks and stimulation conditions. Early study visits will be used to identify optimal stimulation parameters and neural biomarkers associated with disease state. These biomarkers will subsequently be used to implement adaptive DBS, in which stimulation amplitude is automatically adjusted in response to recorded neural activity. Study outcomes will include assessments of safety and feasibility of cerebellar aDBS, as well as preliminary evaluation of its effects on clinical measures.
Frequently Asked Questions
What is Interposed Nucleus aDBS for Ataxia?
Interposed Nucleus aDBS for Ataxia is a clinical trial registered under NCT07325487. Current status: RECRUITING.
What is the status of NCT07325487?
The current status of NCT07325487 (Interposed Nucleus aDBS for Ataxia) is: RECRUITING.
When did Interposed Nucleus aDBS for Ataxia start?
Interposed Nucleus aDBS for Ataxia started on 2026-06-02.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.